Abiopharma

Cerus Corporation - Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update

Cerus Corporation Provides INTERCEPT Red Blood Cell CE Mark Application Update

New Form 6-K - Sanofi Filed: 2025-07-02 AccNo: 0001193125-25-154381 Size: 54 KB

New Form SCHEDULE 13D/A - ARS Pharmaceuticals, Inc. Filed: 2025-07-02 AccNo: 0001193805-25-000963 Size: 18 KB

New Form 4 - Esperion Therapeutics, Inc. Filed: 2025-07-02 AccNo: 0001628280-25-033839 Size: 18 KB

New Form 4 - MYOMO, INC. Filed: 2025-07-02 AccNo: 0000950170-25-092544 Size: 4 KB

New Form 3 - Esperion Therapeutics, Inc. Filed: 2025-07-02 AccNo: 0001628280-25-033837 Size: 16 KB

New Form 4 - MYOMO, INC. Filed: 2025-07-02 AccNo: 0000950170-25-092541 Size: 4 KB

New Form 424B5 - ORAGENICS INC Filed: 2025-07-02 AccNo: 0001641172-25-017466 Size: 549 KB

Nuwellis Appoints John Erb as Chief Executive Officer

Biomerica, Inc. - InFoods IBS receives CPT®Proprietary Laboratory Analysis (PLA) Code

InFoods IBS receives CPT® Proprietary Laboratory Analysis (PLA) Code

New Form 8-K - CareCloud, Inc. Filed: 2025-07-02 AccNo: 0001641172-25-017464 Size: 287 KB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

Nutriband Announces 25% Preferred Stock Dividend as it targets filing for FDA approval

New Form 4 - DYNATRONICS CORP Filed: 2025-07-02 AccNo: 0001062993-25-012414 Size: 4 KB